Literature DB >> 20173382

Successful treatment with paclitaxel/carboplatin chemotherapy in advanced adenocarcinoma of the urinary tract producing carcinoembryonic antigen, carbohydrate antigen 19-9 and carbohydrate antigen 125.

Manabu Kato1, Takehisa Onishi, Akira Hoshina, Tadasihi Yabana.   

Abstract

Primary adenocarcinoma of the urinary tract producing tumor markers is extremely rare. We report 2 cases of advanced adenocarcinoma of the urinary tract producing carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9) and carbohydrate antigen 125 (CA125), which were completely resected after induction chemotherapy with paclitaxel and carboplatin. Patient 1 was a 72-year-old woman with adenocarcinoma of the right renal pelvis and ureter. Patient 2 was a 73-year-old woman with adenocarcinoma of the bladder. Serum levels of CEA, CA19-9 and CA125 were extremely elevated in both cases. They were successfully treated with paclitaxel puls carboplatin followed by surgery. Both patients were proved to have achieved pathological complete regression by surgical specimens and have been alive without recurrence for more than 18 and 6 months, respectively. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20173382     DOI: 10.1159/000273479

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  2 in total

1.  Alpha-fetoprotein and carbohydrate antigen 19-9 producing advanced adenocarcinoma of renal pelvis and ureter.

Authors:  Kai Yang; Xiang-Yi Zheng; Yan-Li Wang; Kui Zhao; Hai Jiang
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

2.  Mucinous adenocarcinoma of the urinary bladder.

Authors:  Giulio Baffigo; Giampaolo Delicato; Daniele Bianchi; Stefano Signore; Edoardo Tartaglia; Francesco Corvese; Alessandro Perla; Bonaventura Marino; Giuseppe Santeusanio; Vincenzo Ferdinandi
Journal:  Am J Case Rep       Date:  2012-06-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.